University of Colorado Anschutz
University of Colorado Anschutz is a public academic medical campus in Aurora, Colorado, operating six professional schools, 40+ degree programs for 4,500 students, and $890M in annual research funding across oncology, neuroscience, and population health, serving over 3 million patient visits annually through UCHealth and Children's Hospital Colorado partnerships.
- Company typePublic
- Founded2004
- HeadquartersAurora, United States
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingServices
What University of Colorado Anschutz does
University of Colorado Anschutz is a public academic medical campus located on the former Fitzsimons Army Medical Center site in Aurora, Colorado, formed through the 2004 consolidation of the University of Colorado Health Sciences Center and the University of Colorado at Denver. The institution operates three integrated mission areas — education, research, and patient care — across six professional schools (Medicine, Nursing, Pharmacy, Dental Medicine, Public Health, and Graduate School), enrolling approximately 4,500 degree-seeking students in over 40 degree programs and serving more than 3 million patient visits annually through its primary clinical partners, UCHealth University of Colorado Hospital and Children's Hospital Colorado. Research output is anchored by $890 million in annual funding ($762M sponsored awards plus $128M philanthropic) and includes flagship capabilities such as the Gates Institute's CD64-directed CAR T-cell therapy (the first FDA-cleared therapy developed entirely on a university campus), the world's first higher-cortex brain-computer interface surgery, and AI-driven diagnostics (e.g., 82–91% accuracy retinal image models for neonatal pulmonary conditions, 87% accuracy Barrett's esophagus recurrence prediction, and Verily Refinery achieving >95% accuracy on complex clinical variables).
The business model combines four revenue streams: tuition and educational program fees across the six schools; sponsored research awards from federal (NIH, NSF, ARPA-H, NIDDK), state, and private funders; clinical care revenue routed through UCHealth; and philanthropic gifts supporting research and capital projects. Strategic capital deployment is active, including a $22.5M acquisition of the Benson Hotel & Faculty Club for patient/family accommodations (March 2026) and participation in Verily Health Inc.'s $300M funding round alongside UCHealth, Alphabet, and Series X Capital. Distribution spans on-campus and NC-SARA-authorized distance education, an embedded partnership ecosystem (ConcertAI CancerLinQ, RefinedScience JV, Mission Bio, City of Hope, Colorado State University, SOL Mental Health), and 57 NCCN cancer guideline adaptations covering over 85% of Sub-Saharan Africa's cancer burden. The institution is led by Chancellor Donald M. Elliman Jr. and CFO Terri Carrothers, operates under The Regents of the University of Colorado, and holds accreditations from HLC, LCME, ACGC, and NC-SARA.
University of Colorado Anschutz firmographics
Firmographics- Name
- University of Colorado Anschutz
- Legal name
- The Regents of the University of Colorado
- Website
- https://cuanschutz.edu
- Company type
- Public
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- University of Colorado Anschutz is a public academic medical campus in Aurora, Colorado, operating six professional schools, 40+ degree programs for 4,500 students, and $890M in annual research funding across oncology, neuroscience, and population health, serving over 3 million patient visits annually through UCHealth and Children's Hospital Colorado partnerships.
- Ownership category
- akta.pro rank
University of Colorado Anschutz industry classification
Industry- Product category
- Academic Medical Center
- NAICS
- Colleges, Universities, and Professional Schools (6113), General Medical and Surgical Hospitals (6221)
- SIC
- Services-Hospitals (8060), Services-Health Services (8000), Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)
- akta.pro secondary industries
- Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Medical Schools (MD/DO Granting) (EDAHAGAB), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
Keywords
Where University of Colorado Anschutz is headquartered
LocationHeadquarters
- HQ city
- Aurora
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
University of Colorado Anschutz business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Tuition and Educational Programs: Revenue from degree programs across six schools including Medicine, Nursing, Pharmacy, Dental Medicine, Public Health, and Graduate School
- Research Grants and Sponsored Awards: $762M in sponsored awards annually from federal, state, and private research funding
- Clinical Care Revenue: Patient care services through UCHealth University of Colorado Hospital serving over 3 million patient visits annually
- Philanthropic Gifts: $128M in annual philanthropic gifts supporting research initiatives
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
University of Colorado Anschutz product offering
Product offeringCore offering
University of Colorado Anschutz is an academic medical campus offering over 40 degree programs across six schools (Medicine, Nursing, Pharmacy, Dental Medicine, Public Health, and Graduate School). The institution delivers advanced biomedical research and clinical care through partnerships with UCHealth University of Colorado Hospital and Children's Hospital Colorado, serving more than 3 million patient visits annually with $890 million in annual research funding.
Product overview
University of Colorado Anschutz is an academic medical campus combining education, research, and patient care across six professional schools (Medicine, Nursing, Pharmacy, Dental Medicine, Public Health, and Graduate School). The institution offers over 40 degree programs and handles over 3 million patient visits annually with approximately $890M in annual research funding. CU Anschutz's technology portfolio includes AI-enabled clinical platforms (Verily Refinery for data transformation, CancerLinQ for oncology insights), novel therapeutics (CD64-directed CAR T-cell therapy, the first FDA-cleared therapy developed entirely on a university campus), medical devices (higher-cortex BCI for paralysis restoration), and decision support tools (Parkinson's DBS decision tool). The institution also leverages single-cell multiomics analysis via the Mission Bio Tapestri platform for CAR-T therapy research.
Differentiator
Problem solved
Functional benefit
Brands
- School of Medicine: Medical education and research school at CU Anschutz
- College of Nursing
- Skaggs School of Pharmacy and Pharmaceutical Sciences
- School of Dental Medicine
- Colorado School of Public Health
- Graduate School
Products and services
- School of Medicine (MD Program)
- College of Nursing Programs
- Skaggs School of Pharmacy and Pharmaceutical Sciences
- School of Dental Medicine
- Colorado School of Public Health
- Graduate School Programs
- CD64-Directed CAR T-Cell Therapy
- Higher-Cortex Brain Computer Interface (BCI)
- Verily Refinery Data Platform
- CancerLinQ Platform Participation
- Parkinson's DBS Decision-Making Tool
- Quality Assurance and Regulatory Affairs Certificate Program
Quantifiable outcome
- First-in-U.S. FDA clearance for campus-developed CAR T-cell therapy for acute myeloid leukemia
- +3 more outcomes
Companies that use University of Colorado Anschutz
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
University of Colorado Anschutz technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability14 records
Feature4 records
University of Colorado Anschutz partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core.
- ConcertAIcoreUniversity of Colorado Anschutz Cancer Center joined ConcertAI's CancerLinQ network, expanding the platform's real-world oncology data coverage. CancerLinQ leverages AI to aggregate and analyze data from over 900 care sites across all 50 states.
- SOL Mental HealthcorePartnership with CU Anschutz Internal Medicine Residency program to provide therapy and psychiatry services to residents, featuring opt-out appointments with confidential provider matching.
- Mission BiocoreResearch collaboration using Mission Bio's Tapestri single-cell multiomics platform to profile vector copy number in CAR-T therapies, achieving 99.2-99.9% sensitivity and 98.8-99.6% specificity.
- City of HopecoreResearch partner with Children's Hospital Colorado and University of Colorado Anschutz on Mission Bio Tapestri platform study for CAR-T therapy vector copy number profiling.
- Children's Hospital ColoradocoreResearch partner on CAR-T therapy studies and pediatric clinical trial following CAR T-cell therapy FDA clearance.
- Verily Health Inc.coreMulti-year strategic collaboration to transform healthcare data usage and patient care delivery using AI and digital technology. Verily's platform aggregates biomedical data to develop AI/ML models across oncology, cardiovascular, neuroscience, and other therapeutic areas. Initial results show over 95% accuracy in Acute Myeloid Leukemia analysis.
- Colorado State Universitycore'Lab to Labrador' collaboration on trauma research focusing on tranexamic acid for severe bleeding, aiming to accelerate approval processes through comparative studies of injury responses in humans and dogs.
- RefinedSciencecoreJoint venture between CU Anschutz and UCHealth focused on drug discovery, working with Verily to develop advanced analytical tools for complex biological data.
- UCHealth University of Colorado HospitalcorePrimary academic medical center partner providing clinical care and hosting clinical trials. Over 3 million patient visits annually.
- Children's Hospital ColoradocoreNationally recognized pediatric academic medical center partnership for children's healthcare and research collaborations.
- University of Colorado MedicinecoreFaculty practice plan providing clinical care through CU Anschutz physicians.
Scale indicators8 records
Recent moves7 records
Expansion highlights7 records
University of Colorado Anschutz competitors and assessment
Company assessmentDirect peers
- Vanderbilt University Medical Center: Vanderbilt is a peer academic medical center with comparable biomedical informatics capabilities, large-scale biobanking (BioVU), and NIDDK-funded diabetes research consortium participation. Both compete for federal informatics and precision medicine grants.
- University of California, San Francisco (UCSF): UCSF is a leading public academic medical center with similar tripartite mission of research, education, and patient care. It competes with CU Anschutz for NIH funding, top faculty, and clinical trial leadership in oncology and translational medicine.
- NYU Langone Health: NYU Langone is a peer academic medical center with strong translational research, multiple health science schools, and similar scale of sponsored research funding. Both compete for top U.S. News rankings and clinical trial leadership.
- Johns Hopkins Medicine: Johns Hopkins is a peer top-5 research institution combining medical education, biomedical research, and patient care. It competes directly for federal research funding, faculty recruitment, and specialized clinical referrals in oncology and neuroscience.
- University of Pennsylvania Health System: Penn Medicine is a top-tier academic medical center with comparable scope across six health science schools, robust CAR T-cell therapy research (pioneered the field), and similar NIH funding scale. Both institutions are leaders in translational gene and cellular therapy research.
- Washington University in St. Louis (BJC HealthCare): Washington University School of Medicine is a comparable top-tier research institution with strong NIH funding, BJC hospital partnership structure, and leading genomics research. Both compete for precision medicine and clinical research leadership.
- Duke University Health System: Duke is a comparable academic medical center with strong translational research programs, NCI-designated cancer center, and clinical partnerships. Both institutions compete for clinical trial enrollment and biotech industry collaboration.
- Stanford Medicine: Stanford Medicine operates as a comparable academic medical center with BCI research leadership (BrainGate program), strong AI/healthcare integration, and substantial NIH funding. It competes for translational research talent and clinical trial sponsorship.
Others
- ConcertAI: ConcertAI is an oncology data platform partner whose CancerLinQ network CU Anschutz joined. Comparable as a healthcare AI ecosystem participant rather than a direct competitor, representing the broader landscape of clinical research data infrastructure providers.
- Verily Health Inc. Verily is a strategic AI/data platform partner (and recent CU Anschutz investor) working with the institution to develop AI-native precision health tools. They are comparable as collaborators in translational data infrastructure rather than direct competitors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
University of Colorado Anschutz social profiles
Digital presenceUniversity of Colorado Anschutz compliance and trust
Trust signalCompliance5 records
University of Colorado Anschutz financial estimates
Financial estimateRevenue estimate
Valuation estimate
University of Colorado Anschutz leadership team
Management profileNumber of profiles
Profiles7 records
University of Colorado Anschutz subsidiaries and ownership
Company hierarchySubsidiaries4 records
University of Colorado Anschutz funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
University of Colorado Anschutz M&A and investment
M&A and investmentM&A
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about University of Colorado Anschutz
What does University of Colorado Anschutz do?
University of Colorado Anschutz is an academic medical campus offering over 40 degree programs across six schools (Medicine, Nursing, Pharmacy, Dental Medicine, Public Health, and Graduate School). The institution delivers advanced biomedical research and clinical care through partnerships with UCHealth University of Colorado Hospital and Children's Hospital Colorado, serving more than 3 million patient visits annually with $890 million in annual research funding.
Is University of Colorado Anschutz a public or private company?
University of Colorado Anschutz is a public company. It is classified as state government owned and is currently operating.
When was University of Colorado Anschutz founded?
University of Colorado Anschutz was founded in 2004. It employs 5,001 to 10,000 people.
Where is University of Colorado Anschutz based?
University of Colorado Anschutz is headquartered in Aurora, United States, in the North America region.
How does University of Colorado Anschutz make money?
Four revenue lines are on record. Tuition and Educational Programs are the primary driver. The others are research Grants and Sponsored Awards, clinical Care Revenue and philanthropic Gifts.
Who are University of Colorado Anschutz's main competitors?
Direct peers on record are Vanderbilt University Medical Center, University of California, San Francisco (UCSF), NYU Langone Health, Johns Hopkins Medicine, University of Pennsylvania Health System, Washington University in St. Louis (BJC HealthCare), Duke University Health System and Stanford Medicine. Others are ConcertAI and Verily Health Inc..
Does University of Colorado Anschutz have an API?
No public API is recorded for University of Colorado Anschutz.
What industry is University of Colorado Anschutz in?
University of Colorado Anschutz's product category is Academic Medical Center. Its primary akta.pro industry code is EDAHAAAC, Public Research Universities with Academic Medical Centers (AMCs), with a secondary code of EDAHAGAA, Academic Medical Centers & Teaching Hospitals (University-Affiliated). Its NAICS code is 6113 and its SIC code is 8060.